AIIMS chief calls for PPP for large-scale rollout of vaccination programme

Photo: Bloomberg

Terming the recent drop in COVID-19 cases in the country as a "small window of opportunity", AIIMS Director Randeep Guleria on Saturday called for a public-private partnership (PPP) for rollout of the COVID-19 vaccination programme at a large scale.

Speaking at an AIMA event here, Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease.

He noted that there was a need to put healthcare at the centrestage and not consider it only as a service sector.

"As far as vaccination is concerned there is still a lot to do and I think there has to be more private public partnership," the All India Institute of Medical Sciences (AIIMS) director said.

There is a need to gradually start opening up in order to cover large number of people, he noted.

"Vaccinating health care workers and front line workers is probably the easy part as far as Phase 1 is concerned as you know who needs to be vaccinated. The number is not that large.

"Once you start the process to vaccinate 27 crore individuals, in that scenario we must have a robust programme in place where you have the list of people to be vaccinated," Guleria said.

He further said: "We need to develop a mechanism where public and private sector actually start rolling out the vaccine at a large scale."

Guleria noted that there is an urgency to roll out the vaccine to a large number of people as there were dosages available due to some level of hesitancy in the healthcare and frontline workers.

"I personally feel we have a window of opportunity available now because our cases are down, but this window can change anytime as we have seen in various parts of the world, specially with new variants coming up from different countries.

"So we should not lose this moment and try to vaccinate a large number of our citizens which will be able to provide some level of protection as far as COVID-19 is concerned," he said.

He added that the country still doesn't have an effective anti viral drug so the only weapon that can be actually utilised is the vaccine.

"We have this small window before things may worsen and therefore we should take whatever vaccine we get and immunise ourselves so that we are able to decrease mortality and really have another spike in cases in the country," Guleria emphasised.

He noted that there has been lot of learning from the pandemic and there should be more emphasis on becoming self-reliant in the healthcare sector.

"What we realised during the initial days of pandemic is that you have to do with stuff which is available in your own country. We had shortage of PPEs, N95 masks and even ventilators because they were not available in the country. Even diagnostics became a challenge. So we have to become self-reliant in many ways and we have to put health at the centrestage," he noted.

Guleria said that health is an important factor as it affects all areas including economy and livelihood.

Rather than looking it only as a service sector, "healthcare should be looked as the centre which could be easily used to push the economy", he said.

He added that the country should not only aspire to become a medical research hub but also the patient care hub for the world.

"I think India has the capacity to do that," he said.

Earlier, speaking the event, Apollo Hospitals vice chairperson Preetha Reddy lauded the government efforts in tackling the COVID-19 pandemic in the country.

She said the country has shown the way to the entire world in dealing with the infectious disease.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel